119-S-1157 Journalist Public Summary
119 · S 1157 Women and Lung Cancer Research and Preventive Services Act of 2025
A bipartisan Senate bill (S. 1157) would have Health and Human Services lead an interagency review—alongside Defense and Veterans Affairs—of what we know (and don’t) about lung cancer in women and underserved groups, how to widen access to screening, and how to run clearer public education, with a report to Congress due within two years; it advanced out of the Senate HELP Committee on January 15, 2026.
Headline Summary
A bipartisan bill would task federal health agencies with mapping gaps in lung‑cancer research for women and underserved communities and proposing ways to expand screening and public awareness, with a report to Congress in two years.
What It Does
S. 1157 (the “Women and Lung Cancer Research and Preventive Services Act of 2025”) directs the Secretary of Health and Human Services—working with the Departments of Defense and Veterans Affairs—to conduct a government‑wide review and recommend ways to: close research gaps on lung cancer in women and underserved populations; improve access to preventive services like screening; and design national education campaigns that stress early detection.
- Runs an interagency review of past and current federally funded research, pinpointing what’s missing for women and underserved groups.
- Explores collaborative, innovative research (including environmental and genomic factors and improved imaging) to better assess risk, diagnose, and treat.
- Considers a national screening strategy to reach eligible people who are currently missed.
- Lays out plans for a public awareness campaign focused on women, underserved populations, and early detection.
- Requires HHS to send Congress a report within two years of enactment.
Who’s For It
- Lead sponsors: Sen. Tina Smith (D‑MN) and Sen. Shelley Moore Capito (R‑WV), indicating bipartisan backing.
- Supporters’ argument (as framed by the sponsors’ goal): better coordination can close research gaps affecting women and underserved communities and help more eligible people get screened earlier.
- Likely allies: lawmakers focused on women’s health, veterans’ health, rural health, and cancer prevention; patient and clinician groups that prioritize earlier detection.
Who’s Against It
- No formal opposition is noted in the provided record so far.
- Potential concerns sometimes raised about similar review/coordination bills: duplication of efforts across agencies; unclear cost or new staffing needs; and preference for directly funding services or research grants rather than commissioning another study.
What’s Next
Status: Introduced March 26, 2025; referred to the Senate Health, Education, Labor, and Pensions (HELP) Committee; on January 15, 2026, the HELP Committee ordered it to be reported favorably with a substitute amendment. Next typical steps are a full Senate vote, then House consideration, and—if passed—signature by the President to become law.
Discussion